Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can different fillers turn back the clock on facial aging?

NCT ID NCT07744464

Symptom relief Sponsor: Antony de Paula Barbosa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study is looking at how well hyaluronic acid dermal fillers with different levels of crosslinking work for facial aesthetic treatment. Twenty adults seeking facial rejuvenation will receive these fillers and be followed for 90 days. Researchers will measure changes using 3D imaging, ultrasound, and satisfaction surveys, while also tracking any side effects. The goal is to see which filler characteristics offer the best balance of effectiveness, safety, and patient satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Injectable hyaluronic acid dermal fillers with different degrees of divinyl sulfone crosslinking
What this could lead to
If successful, this could help refine how dermal fillers are chosen for facial rejuvenation, potentially improving aesthetic outcomes and patient satisfaction.
What could go wrong
This is a small observational study with only 20 participants, so results may not apply broadly. Fillers carry risks like swelling, bruising, or rare complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older. Male or female participants. Seeking facial aesthetic treatment with hyaluronic acid dermal fillers. Clinical indication for treatment according to the investigator's assessment. Willing and able to provide written informed consent. Willing to comply with all scheduled visits, assessments, and follow-up procedures. Able to undergo standardized photographic documentation, three-dimensional facial imaging (Vectra® 3D), ultrasonography, and patient-reported outcome assessments. Exclusion Criteria: * Pregnancy or breastfeeding. Known hypersensitivity to hyaluronic acid or any component of the dermal filler. Active infection, inflammation, or skin disease at the intended treatment site. Previous facial aesthetic procedure that could interfere with study assessments, according to the investigator's judgment. Participation in another clinical study that could affect study outcomes. Any medical condition considered by the investigator to make participation unsafe or interfere with study evaluations. Inability or unwillingness to complete the follow-up schedule or study assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chin deformity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chin deformity Facial aging Facial rhytides Facial volume loss Jawline contour deformity Lip deformity Nasolabial fold Skin aging

Contacts and locations

Locations

  • Instituto Antony Barbosa

    Belo Horizonte, Minas Gerais, 30493-240, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.